doi: 10.1242/10.1242/dev.00422
Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice
Csaba Fülöp1,*,
Sándor Szántó2,
Durba Mukhopadhyay1,
Tamás Bárdos2,
Rajesh V. Kamath2,
Marylin S. Rugg3,
Anthony J. Day3,
Antonietta Salustri4,
Vincent C. Hascall1,
Tibor T. Glant2 and
Katalin Mikecz2
1 Section of Connective Tissue Biology, Department of Biomedical Engineering,
The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
2 Section of Biochemistry and Molecular Biology, Departments of Orthopedic
Surgery and Biochemistry, Rush University at Rush-Presbyterian-St. Luke's
Medical Center, Chicago, Illinois 60612, USA
3 MRC, Immunochemistry Unit, Department of Biochemistry, University of Oxford,
OX1 3QU Oxford, UK
4 Department of Public Health and Cell Biology, University of Rome `Tor
Vergata', 00133 Rome, Italy

View larger version (35K):
[in a new window]
|
Fig. 2. Hematoxylin and eosin stained ovaries from sexually mature (12-week old)
mice. Note the presence of corpus luteum (CL) in all three Tnfip6
genotypes. Scale bar: 500 µm.
|
|

View larger version (45K):
[in a new window]
|
Fig. 3. Lack of fertilizability of oocytes from
Tnfip6/ females. Fertilizability was
assessed by the ability of the oocytes to reach the two-cell stage using in
vivo fertilization. Scale bar: 100 µm.
|
|

View larger version (119K):
[in a new window]
|
Fig. 4. Deficient cumulus mucification in Tnfip6/
females. (A-C) Hematoxylin stained preovulatory follicles in the three
Tnfip6 genotypes 48 hours after the PMSG treatment (before hCG
injection). (D-F) Hematoxylin stained preovulatory follicles 10 hours after
induction of ovulation by hCG injection. (G-L) Localization of hyaluronan
(green) in preovulatory follicles 10 hours after hCG injection. Low (G-I) and
high (J-L) power magnifications are shown. White arrowheads in L point to cell
surface hyaluronan. Nuclei are stained blue by DAPI. Scale bars: 100 µm
(A-I) and 50 µm (J-L).
|
|

View larger version (87K):
[in a new window]
|
Fig. 5. Morphology of ovulated COCs in mice with different Tnfip6
genotypes. Females of all three Tnfip6 genotypes are able to ovulate
as indicated by the presence of oocytes within the oviduct (A-C). The dense
cloud-like material (black arrowheads) around the oocytes in the oviducts of
wild-type and Tnfip6+/ females are the expanded
cumulus layer. Oocytes in the oviduct of the
Tnfip6/ females lack the same dense material
(C, white arrowheads). This difference is clearly seen when isolated COCs are
compared (D-F). COCs from wild-type and heterozygous females show normal
morphology, while oocytes from the homozygotes do not have a cumulus layer.
These latter oocytes are either completely nude (not shown) or they are
associated with a dispersed network of granulosa/cumulus cells (F). Scale
bars: 100 µm.
|
|

View larger version (122K):
[in a new window]
|
Fig. 6. Impaired expansion of Tnfip6/ COCs in
vitro. (A-I) Compact COCs (48 hours after PMSG injection) from the three
Tnfip6 genotypes were cultured in the absence (A-C) or in the
presence of either 3 ng/ml EGF (D-F) or 1 mM dbcAMP (G-I). (J-K) Expansion of
Tnfip6/ COCs can be restored by
supplementing recombinant TNFIP6 in the culture medium. Scale bars: 100
µm.
|
|

View larger version (23K):
[in a new window]
|
Fig. 8. Schematic model for the proposed role of TNFIP6 in the stabilization of the
cumulus extracellular matrix. For simplicity, only two hyaluronan chains are
shown, but the proposed interactions can crosslink many of these chains
creating a very stable hyaluronan meshwork. Asterisks indicate covalent
interactions (ester bonds) between the heavy chains (HCs) and hyaluronan. All
other protein-hyaluronan interactions are non-covalent. The presence of HC(1
or 2)-TNFIP6 complexes in the cumulus matrix was demonstrated in our previous
study (Mukhopadhyay et al.,
2001 ). Note that the exact structure of the HC-TNFIP6 has not yet
been elucidated, therefore two hypothetical complex structures are shown. `?'
indicates that no HC3-TNFIP6 complex has been detected yet. CS, chondroitin
sulfate.
|
|
© The Company of Biologists Ltd 2003